Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings-Reference-Cited by-同舟云学术

Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings

Published:2015 Issue:1 Volume:26 Page:46
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Wilailak Sarikapan¹,Chan Karen KL²,Chen Chi-An³,Nam Joo-Hyun⁴,Ochiai Kazunori⁵,Aw Tar-Choon⁶,Sabaratnam Subathra⁷,Hebbar Sudarshan⁸,Sickan Jaganathan⁸,Schodin Beth A⁸,Charakorn Chuenkamon¹,Sumpaico Walfrido W⁹

Affiliation:

1. Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

2. Department of Obstetrics and Gynecology, University of Hong Kong, Hong Kong.

3. Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan.

4. Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

5. Department of Obstetrics and Gynecology, The Jikei University, Tokyo, Japan.

6. Department of Laboratory Medicine, Changi General Hospital, Singapore.

7. Department of Pathology, Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.

8. Abbott Diagnostics, Abbott Park, IL, USA.

9. Department of Obstetrics and Gynecology, MCU-FDT Medical Foundation, Caloocan, Philippines.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

http://synapse.koreamed.org/pdf/10.3802/jgo.2015.26.1.46

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Four Different Risk Malignancy Indices in Differentiating Benign and Malignant Ovarian Masses;Journal of Mid-life Health;2024-04

2. Diagnostic, prognostic, and therapeutic biomarkers of ovarian cancer;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

3. A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer;Cancers;2023-11-02

4. Evaluation of Human Epididymis Protein 4, Risk of Ovarian Malignancy Algorithm, and Risk of Malignancy Index Efficiency for Ameliorating Sensitivity and Specificity for Differentiating Benign from Malignant Adnexal Masses;Journal of Laboratory Physicians;2023-09-25

5. Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses;Medicine;2023-09-15